MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$135,262K
Cash and cash
equivalents
$15,229K
Other current assets
$14,444K
Prepaid expenses
$11,543K
Accounts receivable
$10,038K
Total property and
equipment
$192,879K
Total current assets
$186,516K
Property and equipment,
net
$101,874K
Operating lease
right-of-use assets
$45,541K
Other assets
$5,513K
Restricted cash
$2,030K
Accounts receivable
$420K
Accumulated depreciation
and amortization
$91,005K
Total assets
$341,894K
Total liabilities and
stockholders equity
$341,894K
Total liabilities
$320,812K
Total stockholders
equity
$21,082K
Accumulated deficit
-$1,216,078K
Accumulated other
comprehensive loss
-$870K
Royalty monetization
liabilities
$163,105K
Total current
liabilities
$71,110K
Operating lease
liabilities
$63,199K
Deferred revenue
$22,776K
Other liabilities
$622K
Additional paid-in capital
$1,238,025K
Common stock 0.0001 par
value 100,000 shares...
$5K
Accrued expenses and
other current...
$21,892K
Accounts payable
$21,207K
Royalty monetization
liabilities
$14,225K
Operating lease
liabilities
$7,867K
Deferred revenue
$5,919K
Back
Back
Balance Sheet
REGENXBIO Inc. (RGNX)
REGENXBIO Inc. (RGNX)
source: myfinsight.com